NASDAQ: DRTS
Alpha Tau Medical Ltd Stock Ownership - Who owns Alpha Tau Medical?

Insider buying vs selling

Have Alpha Tau Medical Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Raphi LevyChief Financial Officer2026-06-0317,500$10.90
$190.75kSell
Raphi LevyChief Financial Officer2026-06-0315,000$10.76
$161.36kSell

1 of 1

DRTS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DRTS insiders and whales buy or sell their stock.

DRTS Shareholders

What type of owners hold Alpha Tau Medical Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Hightower Advisors LLC0.99%874,994$8.62MInstitution
Aquamarine Financial Cayman Ltd0.82%721,501$7.11MInstitution
Apella Capital LLC0.43%382,284$3.77MInstitution
Michael Avruch0.37%325,700$3.21MInsider
Ark Investment Management LLC0.33%292,134$2.88MInstitution
Ubs Group Ag0.33%286,688$2.82MInstitution
Raphi Levy0.17%147,680$1.45MInsider
Northcoast Asset Management LLC0.17%147,138$1.45MInstitution
Mariner LLC0.17%146,396$1.44MInstitution
Daytona Street Capital LLC0.17%146,106$1.44MInstitution

1 of 3

DRTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DRTS4.61%0.68%Net SellingNet Selling
OLMA80.05%19.95%Net Selling
TBPH53.67%46.33%Net SellingNet Selling
ORIC84.79%15.21%Net Selling
LXRX21.87%78.13%Net Buying

Alpha Tau Medical Stock Ownership FAQ

Who owns Alpha Tau Medical?

Alpha Tau Medical (NASDAQ: DRTS) is owned by 4.61% institutional shareholders, 0.68% Alpha Tau Medical insiders, and 94.71% retail investors. Michael Avruch is the largest individual Alpha Tau Medical shareholder, owning 325,700.00 shares representing 0.37% of the company. Michael Avruch's Alpha Tau Medical shares are currently valued at $3.21M.

If you're new to stock investing, here's how to buy Alpha Tau Medical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.